Irving Medical Center
the Food and Drug Administration
FDA
Veklury
Nature Communications
the American Heart Association
ARDS
Brigham and Women’s Hospital
MA
the Novavax COVID-19
Aakriti Gupta
Mahesh V. Madhavan
Behnood Bikdeli
COVID-19
Western
No matching tags
No matching tags
the United States
New York
MD
NewYork
Singapore
U.S.
Boston
Iran
No matching tags
They also matched patients in each group to reduce major differences in demographics, other medication use, and conditions that increase the risk of severe COVID-19.Based on their analysis, in the study, 14.8% of people taking statins died in hospital within a month of being admitted versus 26.5% of patients not taking statins. Madhavan, MD, a cardiologist at NewYork-Presbyterian/Columbia University Irving Medical Center.Researchers will also have to figure out whether the effectiveness or usefulness of statins in treating COVID-19 varies between populations and countries.Right now, several randomized studies are underway to find out whether statin use can reduce the risk of hospitalization for COVID-19 and the risk of death in hospitalized patients.
As said here by https://www.medicalnewstoday.com/articles/statin-users-50-less-likely-to-die-in-hospital-from-severe-covid-19